Recent studies demonstrated that germline mutations in BRCA1 and BRCA2 can be essential in identifying men with higher risk of developing PCa, and are associated with a more aggressive phenotype and poorer outcome when mutated [48,49,50,51]. This evidence concerns the gene BRCA1 and posterior cortical atrophy.